Literature DB >> 15835889

Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid.

Kimberly L Sciarretta1, David J Gordon, Aneta T Petkova, Robert Tycko, Stephen C Meredith.   

Abstract

Recent solid-state NMR data (1) demonstrate that Abeta(1)(-)(40) adopts a conformation in amyloid fibrils with two in-register, parallel beta-sheets, connected by a bend structure encompassing residues D(23)VGSNKG(29), with a close contact between the side chains of Asp23 and Lys28. We hypothesized that forming this bend structure might be rate-limiting in fibril formation, as indicated by the lag period typically observed in the kinetics of Abeta(1)(-)(40) fibrillogenesis. We synthesized Abeta(1)(-)(40)-Lactam(D23/K28), a congener Abeta(1)(-)(40) peptide that contains a lactam bridge between the side chains of Asp23 and Lys28. Abeta(1)(-)(40)-Lactam(D23/K28) forms fibrils similar to those formed by Abeta(1)(-)(40). The kinetics of fibrillogenesis, however, occur without the typical lag period, and at a rate approximately 1000-fold greater than is seen with Abeta(1)(-)(40) fibrillogenesis. The strong tendency toward self-association is also shown by size exclusion chromatography in which Abeta(1)(-)(40)-Lactam(D23/K28) forms oligomers even at concentrations of approximately 1-5 microM. Under the same conditions, Abeta(1)(-)(40) shows no detectable oligomers by size exclusion chromatography. Our data suggest that Abeta(1)(-)(40)-Lactam(D23/K28) could bypass an unfavorable folding step in fibrillogenesis, because the lactam linkage "preforms" a bendlike structure in the peptide. Consistent with this view Abeta(1)(-)(40) growth is efficiently nucleated by Abeta(1)(-)(40)-Lactam(D23/K28) fibril seeds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15835889     DOI: 10.1021/bi0474867

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  82 in total

1.  Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.

Authors:  Takeshi Sato; Pascal Kienlen-Campard; Mahiuddin Ahmed; Wei Liu; Huilin Li; James I Elliott; Saburo Aimoto; Stefan N Constantinescu; Jean-Noel Octave; Steven O Smith
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  Impact of chemical heterogeneity on protein self-assembly in water.

Authors:  Song-Ho Chong; Sihyun Ham
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-26       Impact factor: 11.205

3.  Amyloid-beta fibrillogenesis seeded by interface-induced peptide misfolding and self-assembly.

Authors:  Eva Y Chi; Shelli L Frey; Amy Winans; Kin Lok H Lam; Kristian Kjaer; Jaroslaw Majewski; Ka Yee C Lee
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

4.  N-Terminal Charged Residues of Amyloid-β Peptide Modulate Amyloidogenesis and Interaction with Lipid Membrane.

Authors:  Clifford Morris; Shirin Cupples; Thomas W Kent; Esmail A Elbassal; Ewa P Wojcikiewicz; Peng Yi; Deguo Du
Journal:  Chemistry       Date:  2018-06-06       Impact factor: 5.236

5.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

6.  Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations.

Authors:  Alexis Huet; Philippe Derreumaux
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

7.  Determining the critical nucleus and mechanism of fibril elongation of the Alzheimer's Abeta(1-40) peptide.

Authors:  Nicolas Lux Fawzi; Yuka Okabe; Eng-Hui Yap; Teresa Head-Gordon
Journal:  J Mol Biol       Date:  2006-10-07       Impact factor: 5.469

8.  Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study.

Authors:  Sijung Yun; B Urbanc; L Cruz; G Bitan; D B Teplow; H E Stanley
Journal:  Biophys J       Date:  2007-02-16       Impact factor: 4.033

Review 9.  Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.

Authors:  Qin Nie; Xiao-guang Du; Mei-yu Geng
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

10.  Protofibril assemblies of the arctic, Dutch, and Flemish mutants of the Alzheimer's Abeta1-40 peptide.

Authors:  Nicolas Lux Fawzi; Kevin L Kohlstedt; Yuka Okabe; Teresa Head-Gordon
Journal:  Biophys J       Date:  2007-11-21       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.